Clinical trial
Tonabersat in the Prophylaxis of Migraine With Aura
NCT00332007 · Minster Research Ltd, Industry · Completed
Key facts
| NCT number | NCT00332007 |
|---|---|
| Title | Tonabersat in the Prophylaxis of Migraine With Aura |
| Official title | A Single Centre, Double-blind, Randomised, Placebo Controlled Crossover Study to Evaluate the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine in Patients Presenting With Migraine With Aura |
| Lead sponsor | Minster Research Ltd, Industry |
| Collaborators | University of Copenhagen |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine With Aura |
| Intervention type | Drug |
| Interventions | Tonabersat, Placebo |
| Enrollment | 39 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | May 31, 2006 |
| Last update posted | Aug 31, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: